Adjusting PSA Scores For Obese Men Or Cancers May Be Missed

"Obese men have more blood circulating throughout their bodies than normal weight men, and as a result, the concentration of prostate-specific antigen, or PSA, in the blood -- the gold standard for detecting prostate cancer -- can become diluted," said Stephen Freedland, M.D., a Duke urologist and senior researcher on the study.*

"We've known for a while that obese men tend to have lower PSA scores than normal weight men, but our study really proposes a reason why this happens, and points to the need for an adjustment in the way we interpret PSA scores that will take body weight into account. If not, we may be missing a large number of cancers each year."

Researchers compared the medical records of almost 14,000 patients who had undergone radical prostatectomy surgery for the treatment of prostate cancer between 1988 and 2006 at Johns Hopkins, Duke, or at one of five Veterans Affairs hospitals making up the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort. They analyzed the relationship between body mass index -- which is a measure of obesity -- and PSA concentration levels, while also examining the blood volume in the patients' bodies and the total amount of PSA protein found in the blood, known as PSA mass, Freedland said.

"We found that a higher body mass index directly correlated with higher blood volume and lower PSA concentrations," said Lionel Bañez, M.D., a prostate cancer researcher in the Duke Prostate Center and lead author on the publication. "Men in the most obese group had PSA concentrations that were 11 to 21 percent lower than those of normal weight men."

In this study, PSA mass across all groups was comparable despite differences in body weight, leading the researchers to believe that the larger blood volume is responsible for lowering the concentration of PSA, which is what doctors typically measure when looking for prostate cancer, Freedland said.

"It's as if you dissolve a tablet in a cup of water versus a tub of water," he said. "The concentration of the drug in the cup will be much higher than that in the tub, even though the amount is the same."

These findings are very important because of the sheer number of people they affect, Freedland said.

"One in three Americans is obese, and it's not just the very large people that you think of who fall into this category," he said. A man who is 5'11" and weighs 215 pounds is considered obese.

"Our study shows yet another potentially serious consequence of this country's growing epidemic of obesity," said Carmen Rodriguez, MD, an American Cancer Society epidemiologist and co-author of the study. "Previous studies have linked obesity to more aggressive prostate cancers. Our finding that prostate cancer may also be more difficult to detect in this population generates a dangerous 'one-two punch' for men who are overweight or obese."

If their prostate cancers are being detected later because of the dilution of PSA, this may help, in part, to explain why obese men tend to have more aggressive cancers, Freedland said.

*Journal reference: JAMA. 2007;298(19):2275-2280.

Other study authors include Robin Vollmer, Leon Sun and Judd Moul of Duke; Robert Hamilton of the University of Toronto; Alan Partin of Johns Hopkins; Yiting Wang of the American Cancer Society; Martha Terris of the Medical College of Georgia; William Aronson of UCLA; Joseph Presti of Stanford; Christopher Kane of the University of California-San Francisco; and Christopher Amling of the University of Alabama-Birmingham.

The study was funded by the Department of Veterans Affairs, the Duke Department of Surgery and Division of Urology, the Department of Defense Prostate Cancer Research Program, the American Urological Association Foundation, the Georgia Cancer Coalition, and the National Institutes of Health.